Press release – 12.07.2017

Theraclion’s Echopulse® Covered by French National Health Insurance for the Treatment of Breast Fibroadenomas

 

The treatment of breast fibroadenomas with high intensity focused ultrasound (HIFU) is covered within the Forfait Innovation process

 

THERACLION today announced the publication in the Official Gazette of the order relating to the reimbursement for its medical device Echopulse® for the treatment of breast adenofibromas, pursuant to Article L. 165-1-1 of the Code of Social Security: https://www.legifrance.gouv.fr/eli/arrete/2017/6/28/SSAH1719144A/jo/texte

 

Read the press release

Print Friendly